Search for European Projects

12 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Tribbles Research and Innovation Network (TRAIN)

Start date: Sep 1, 2016, End date: Aug 31, 2020,

This proposal was developed in the context of the medical need to tackle the clinical consequences of obesity-related diseases more holistically. Dysregulation of common molecular pathways that govern the physiological functioning of adipocytes, immune cells and prostate epithelium cells have been reported in immuno-metabolic disease (such as obesity) and several cancers. The individual projects ...
Read Project

 10

 FINISHED 

A training network for the rational design of the next generation of well-defined glycoconjugate vaccines (GLYCOVAX)

Start date: Nov 1, 2015, End date: Oct 31, 2019,

GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defined and innovative glycoconjugate vaccines to improve current preventive therapies and to tackle unmet medical needs. Glycoconjugate vaccines represent the key for success of vaccination in children. The covalent linkage to proteins renders carbohydrates able ...
Read Project

 12

 FINISHED 

First Chemoselective Synthesis and Structural Studies of Lasso Peptides (FCSSSLP)

Start date: Jul 5, 2016, End date: Jul 4, 2019,

The main objective of this project is to promote the use of peptides as potential therapeutic agents. We now know that ribosomal peptides, and specifically lasso peptides, which are biosynthesized by bacteria as agents of defense, show a compact and rigid structure, giving a high stability against physical, chemical and proteolytic degradation. The spectrum of biological activities of these peptid ...
Read Project

 1

 FINISHED 

Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. (TOLLerant)

Start date: Jan 1, 2015, End date: Dec 31, 2018,

Based on an international team derived from the COST action BM1003 (www.cost-bm1003.info, 2011-2014) and thus relying on consolidated group interactions and synergies and on a unique combination of chemistry, biology, biophysics, biochemistry and pharmacology expertise, the TOLLerant project aims to gain information on molecular aspects of TLR4 activation and signaling by using synthetic and natur ...
Read Project

 10

 FINISHED 

Anti-tick Vaccines to Prevent Tick-borne Diseases in Europe (ANTIDotE)

Start date: Dec 1, 2013, End date: Nov 30, 2018,

Background Ixodes ricinus transmits bacterial, protozoal and viral pathogens that cause Lyme borreliosis, babesiosis and tick-borne encephalitis respectively and exceedingly affect Central and Eastern Europe (CEE). During feeding, ticks introduce salivary proteins in the skin that interfere with host defense mechanisms. However, in animals repeated tick infestations as well as vaccination against ...
Read Project

 8

 FINISHED 

Metabolic requirements for prostate cancer cell fitness (CancerMetab)

Start date: Nov 1, 2013, End date: Oct 31, 2018,

The actual view of cellular transformation and cancer progression supports the notion that cancer cells must undergo metabolic reprogramming in order to survive in a hostile environment. This field has experienced a renaissance in recent years, with the discovery of cancer genes regulating metabolic homeostasis, in turn being accepted as an emergent hallmark of cancer. Prostate cancer presents one ...
Read Project

 1

 FINISHED 

Unravelling the Nascent Code: Signals sensed and transmitted by the nascent chain to acquire its functional state or reprogram gene expression (THE NASCENT CODE)

Start date: Jul 14, 2014, End date: Jul 13, 2018,

"Emerging biochemical and biophysical data strongly suggest that the transformation of the potential set of proteins, encrypted in the genome, into its actual vital functional set, is a manifestation not just of the genetic code, but of an additional layer of information encoded within the newly synthesized polypeptide nascent chain. To date, we know that immediately upon the first steps of protei ...
Read Project

 1

 FINISHED 

Novel vaccine and diagnostic strategies against Schmallenberg virus (SchmaVirusVacDiag)

Start date: Jun 15, 2015, End date: Jun 14, 2017,

Schmallenberg virus (SV) is a pathogen that has been discovered in European livestock 3 years ago. Since then, it has been found that this virus is associated with disease in sheep, goats and cattle across Europe . In livestock, the symptoms associated with the disease include stillbirths and malformations in newborn animals. The presence of the virus in Spain, France, Germany, Italy, the UK, t ...
Read Project

 1

 FINISHED 

Cholesterol metabolism as a driver of prostate cancer aggressiveness (ACM)

Start date: Apr 1, 2015, End date: Mar 31, 2017,

According to the WHO, prostate cancer (PCa) is the most common cancer in men in the European Union (EU). The current view of cellular transformation and cancer progression supports the notion that cancer cells must undergo a metabolic reprogramming in order to survive in a hostile environment. Tumors are not homogeneous entities, and most cancers retain a differential fraction of cells with increa ...
Read Project

 1

 FINISHED 

Implication of energy sensing pathways in prostate cancer biology (PTENLKB1)

Start date: Jan 2, 2012, End date: Jan 1, 2016,

"Prostate cancer is among the most prevalent forms of cancer in men and the fifth cause of dead from cancer in men worldwide. Therefore, the understanding of prostate cancer biology is a key step in the development of new effective therapeutic approaches. In this line, the use of genetically engineered mouse models has been critical in the understanding of the genetic cues that regulate the proces ...
Read Project

 1

 FINISHED 

European Research Training in the Ubiquitin Proteasome System (UPStream)

Start date: Nov 1, 2011, End date: Oct 31, 2015,

The main objective of the international training network UPStream is the training of a novel generation of European scientist in a critical and complex field of modern biology: the understanding of the regulation of the UPS and its potential use for drug development. The importance of this process is illustrated by the imperious necessity to destroy certain proteins during several phases of the ce ...
Read Project

 10

 FINISHED 

Integration of Novel Nanoparticle based Technology for Therapeutics and Diagnosis of different types of Cancer (NANOTHER)

Start date: Sep 1, 2008, End date: Aug 31, 2012,

The breakthrough objective of NANOTHER is to develop & characterise a novel nanoparticle system that will be used as a therapeutic agent or diagnosis tool for breast cancer, colorectal cancer & bone metastasis. Theranostics, the development of nanoparticles with both functionalities, will also be carried out using the hyperthermic effect to kill tumour cells or to release the selected drug . The n ...
Read Project

 19